Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Extension Study of QWO for Cellulite
NCT03526549Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Apr 2018
- Primary completion
- Oct 2021
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in cellulite, sponsored by Endo International plc. Started Apr 2018; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT03526549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03526549.